Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807900
ONCOGENETICS
1837
POSTER PRESENTATION

Germline testing recommendation (GTR) in non-small cell lung cancer (NSCLC) after broad tumor sequencing: evaluating the impact of more/less conservative criteria from ESMO/ASCO

Authors

  • Breno Jeha Araújo

  • Rodrigo Dienstmann

Further Information
  All articles of this category

Keywords

Germline testing - Non-Small Cell Lung Cancer (NSCLC) - Next-generation Sequencing (NGS)


Publication History

Article published online:
06 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Breno Jeha Araújo, Rodrigo Dienstmann. Germline testing recommendation (GTR) in non-small cell lung cancer (NSCLC) after broad tumor sequencing: evaluating the impact of more/less conservative criteria from ESMO/ASCO. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807900